Stock AVRO AVROBIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar AVROBIO, Inc.

Equities

AVRO

US05455M1009

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.21 USD +2.11% Intraday chart for AVROBIO, Inc. +0.83% -11.03%
Mar. 21 North American Morning Briefing : Investors -2- DJ
Mar. 14 AVROBIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar AVROBIO, Inc.

649dfe0d5c38dfe.DjT7anH9TwnWHSM1ChbLfwvU_Utn_sKJjuDTzQdrVWo.dhmyCCCFG3-hURJ8VUOfHU6ViRMGibbC4ZLg_U8SDCU-BZdZA80LQ6R8Ew~e6f5e0893baa348a8f629763243e9a33

Upcoming events on AVROBIO, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)

Past events on AVROBIO, Inc.

2024-01-30 08:30 am Avrobio, Inc. and Tectonic Therapeutic, Inc. Merger Agreement Call
2023-06-06 09:00 am Annual General Meeting
2023-05-18 06:45 pm American Society of Gene and Cell Therapy Meeting
2023-05-11 07:00 am Q1 2023 Earnings Release
2023-03-23 07:00 am Q4 2022 Earnings Release
2023-03-07 10:30 am Cowen Health Care Conference - Panel
2023-02-25 04:00 pm WORLD Symposium
2023-02-25 09:00 am WORLD Symposium - Phase 1/2 study evaluating AVR-RD-02
2023-02-25 09:00 am WORLD Symposium
2023-02-23 03:00 pm WORLD Symposium
2023-02-23 02:00 pm WORLD Symposium
2023-02-23 08:00 am WORLD Symposium
2022-12-07 08:00 am Business Update Call
2022-11-14 12:30 pm Barclays Gene Editing/Therapy Summit
2022-11-08 07:00 am Q3 2022 Earnings Release
2022-10-13 12:30 pm European Society of Gene & Cell Therapy Congress
2022-09-13 01:30 pm Morgan Stanley Global Healthcare Conference
2022-09-12 07:00 am H.C. Wainwright Global Investment Conference - Pre-recorded
2022-09-06 Wells Fargo Healthcare Conference
2022-09-05 Citi BioPharma Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		-75,0
-70,7
-5.99%		-119
-125
5.03%		-117
-122
3.46%		-104
-110
5.06%		-71,1
-79,3
10.4%
-77,6

EBIT
Million USD		Released
Forecast
Spread 		-75,8
-71,9
-5.47%		-120
-126
4.44%		-119
-124
3.86%		-105
-104
-1%		-71,7
-74,2
3.41%
-77,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-73,0
-70,1
-4.07%		-120
-125
4.14%		-119
-124
3.74%		-106
-103
-2.86%		12,5
9,93
26.18%
-77,0

Net income
Million USD		Released
Forecast
Spread 		-73,0
-69,9
-4.37%		-120
-125
4.14%		-119
-124
3.74%		-106
-103
-2.86%		12,2
9,93
22.39%
-77,0

EPS
USD		Released
Forecast
Spread 		-2,66
-2,55
-4.5%		-3,31
-3,49
5.02%		-2,78
-2,88
3.47%		-2,42
-2,20
-10.08%		0,27
0,22
20.9%
-0,65

Announcement Date16/03/2018/03/2117/03/2223/03/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
17,5
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00




EBIT
Million USD		Released
Forecast
Spread 		-28,0
-32,9
15.1%		-29,4
-26,4
-11.32%		-27,8
-26,9
-3.41%		-23,0
-25,5
9.7%		-25,3
-22,3
-13.33%		-25,2
-24,8
-1.79%		-15,7
4,38
-459.44%		-21,1
-12,8
-64.77%		-9,63
-11,6
16.65%
-16,0


-16,0


-20,0


-25,0




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-28,2
-32,9
14.09%		-29,8
-26,3
-13.52%		-28,1
-26,8
-4.59%		-23,0
-25,4
9.58%		-25,0
-22,2
-12.77%		-25,0
-24,6
-1.28%		67,5
4,42
1427.3%		-21,6
-12,6
-71.93%		-8,41
-11,3
25.59%
-16,0


-16,0


-20,0


-25,0




Net income
Million USD		Released
Forecast
Spread 		-28,2
-32,9
14.09%		-29,8
-26,3
-13.52%		-28,1
-26,8
-4.59%		-23,0
-25,4
9.58%		-25,0
-22,2
-12.77%		-25,0
-24,7
-1.07%		67,5
17,3
289.55%		-21,6
-12,6
-71.93%		-8,79
-11,3
22.26%
-16,0


-16,0


-20,0


-25,0




EPS
USD		Released
Forecast
Spread 		-0,65
-0,75
13%		-0,68
-0,57
-19.3%		-0,64
-0,55
-16.72%		-0,52
-0,53
1.27%		-0,57
-0,45
-28.09%		-0,57
-0,56
-1.42%		1,52
-0,55
376.36%		-0,48
-0,29
-68.42%		-0,20
-0,26
21.57%
-0,36


-0,08


-0,10


-0,13


-0,12

Announcement Date17/03/2210/05/2209/08/2208/11/2223/03/2311/05/2310/08/2309/11/2314/03/24-----

Upcoming sector events for AVROBIO, Inc.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for AVROBIO, Inc.

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AVRO Stock
  4. Calendar AVROBIO, Inc.